:

Esika Savsani1, Colette M Shaw1, Flemming Forsberg1

  • 1From the Department of Radiology (E.S., C.M.S., F.F., C.E.W., A.L., P.O., J.B.L., R.B., C.G.R., H.N., A.T., K.A., K.B., J.R.E.), Sidney Kimmel Medical College (E.S.), Division of Biostatistics, Department of Pharmacology, Physiology, and Cancer Biology (S.W.K.), and Department of Medicine (J.C.), Thomas Jefferson University, 132 S 10th St, 796 E Main Building, Philadelphia, PA 19107; Department of Radiology, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pa (S.S., S.S.N., S.H., M.C.S.); Department of Radiology, University of Texas Southwestern Medical Center, Dallas, Tex (R.F.M.); Cancer Prevention and Research Institute of Texas, Austin, Tex (R.F.M.); and Departments of Medicine and Radiology, University of California, San Diego, La Jolla, Calif (Y.K.).

Radiology
|October 17, 2023
PubMed
概括

与MRI/CT相比,对比增强超声波 (CE US) 在TACE后检测残留肝细胞癌 (HCC) 的灵敏度更高. 不管后续时间如何,CE US的业绩始终保持一致.

相关概念视频